Two Seas Capital LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $611 Million distributed in 34 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $120M, Vistra Corp. with a value of $52.3M, Immunovant, Inc. with a value of $41.6M, Sotera Health CO with a value of $39.6M, and Arbutus Biopharma Corp with a value of $28.6M.

Examining the 13F form we can see an increase of $313M in the current position value, from $297M to 611M.

Two Seas Capital LP is based out at Rye, NY

Below you can find more details about Two Seas Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $611 Million
Healthcare: $261 Million
ETFs: $219 Million
Utilities: $74.4 Million
Communication Services: $30.9 Million
Financial Services: $15.4 Million
Technology: $7.96 Million
Industrials: $1.55 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 34
  • Current Value $611 Million
  • Prior Value $297 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 6 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Two Seas Capital LP Portfolio

Follow Two Seas Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Seas Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Seas Capital LP with notifications on news.